• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » LeMaitre Vascular pays $5M for Neovasc’s XenoSure | Wall Street Beat

LeMaitre Vascular pays $5M for Neovasc’s XenoSure | Wall Street Beat

October 2, 2012 By MassDevice staff

MassDevice.com Wall Street Beat

LeMaitre Vascular (NSDQ:LMAT) said it will pay $4.6 million for Neovasc’s (NYSE:NVC) XenoSure vascular patch, used to repair blood vessels.

The Burlington, Mass.-based medical device company won exclusive distribution rights for XenoSure in 2009, according to a press release, booking revenues of $2.8 million during fiscal 2010 and $4.5 million in FY2011 from sales of the patch.

“Following the manufacturing transfer, we expect our XenoSure gross margin will improve from approximately 50% to 65%. In addition, this option exercise will enable us to extend and enhance the product line,” LeMaitre president David Roberts said in prepared remarks.

Sign up to get our free newsletters delivered straight to your inbox

 Corpak buys Merck’s UK, Irish gastro biz
Corpak MedSystems said it plans to buy Merck’s (NYSE:MRK) gastroenterology sales and distribution operation in the UK and Ireland.
Read more

 Cambridge Heart preps for debt default, halves CFO’s pay
Cambridge Heart (NSDQ:CAMH) said it’s preparing to default on about $3.8 million worth of debt and only has enough cash on hand to make it through October. The company also said CFO Vincenzo LiCausi agreed to cut his salary in half.
Read more

 BCG: Medtech makers costs’ "unsustainable"
Medical device companies must adjust their business models in the face of "relentless pricing pressures" as their customer base shifts, according to a report from the Boston Consulting Group.
Read more

 Analysts’ ups and downs

  • Boston Scientific (NYSE:BSX): J.P. Morgan maintains “neutral” rating.
  • Globus Medical (NYSE:GMED): Piper Jaffray reiterates Overweight rating, raises price target from $18 to $21.
  • Intuitive Surgical (NSDQ:ISRG): Raymond James maintains “outperform” rating
  • Medtronic (NYSE:MDT): Wells Fargo maintains “outperform” rating
  • Sunshine Heart (ASX:SHC): Canaccord Genuity reiterates Buy rating, raises price target from $11 to $12.50.

Filed Under: Mergers & Acquisitions, News Well, Wall Street Beat Tagged With: Boston Consulting Group, Cambridge Heart Inc., Corpak Medsystems Inc., LeMaitre Vascular Inc., Merck, neovasc

More recent news

  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech
  • Neurent Medical wins FDA nod for next-gen chronic rhinitis treatment
  • Medtronic unveils “MiniMed” as name for soon-to-be separated Diabetes unit
  • Medtronic issues safety notice for Hugo surgical robot console in Europe

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy